Found 9 matching trials
Convalescent Plasma to Limit Coronavirus Associated Complications
PHASE2Researchers are trying to assess the treatment potential and safety of anti...
Location
Multiple Locations
Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
PHASE2This study is a 4-arm, multicenter, randomized, partly double- blind, contr...
Location
Abteilung Infektiologie Klinik für Innere Medizin II Department Innere Medizin Universitätsklinikum Freiburg
ChulaCov19 Vaccine in Healthy Adults
PHASE1This study will be conducted in 2 phases. Phase 1 of this study will be a s...
Location
Chula Vaccine Research Center (ChulaCRC) Faculty of Medicine Chulalongkorn University
Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection
PHASE3After SARS-COV-2 inactivated vaccine authorization for use in different cou...
Location
Zagazig University Faculty of Medicine
Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients
PHASE2The purpose of this research study is to find out if CCP is safe and to det...
Location
University of North Carolina Health Care
Association of Phenotypic Age and Antibody Titers Among SARS-Co-V2 Infected Patients and Vaccinated Groups
N/ADefining the antibody response to SARS-CoV-2 will be essential for understa...
Collection of Anti-SARS-CoV-2 Immune Plasma
N/ABackground:
The human disease caused by SARS-CoV-2 is called COVID-19. In ...
Location
Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center
Convalescent Plasma as a Possible Treatment for COVID-19
PHASE2Patients who are ill with COVID-19 may benefit from receiving convalescent ...
Location
University of Illinois at Chicago
Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection
NAThis is a multicenter, Phase 2 study, to assess the efficacy of the treatme...
Location
"Evangelismos" General Hospital